The Manufacturers Life Insurance Company Takes Position in Integer Holdings Corporation $ITGR

The Manufacturers Life Insurance Company bought a new position in Integer Holdings Corporation (NYSE:ITGR) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 544,942 shares of the medical equipment provider’s stock, valued at approximately $50,925,000. The Manufacturers Life Insurance Company owned approximately 1.60% of Integer as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC raised its position in Integer by 48.1% during the first quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 117 shares in the last quarter. Kestra Advisory Services LLC boosted its holdings in shares of Integer by 0.6% in the 4th quarter. Kestra Advisory Services LLC now owns 21,424 shares of the medical equipment provider’s stock worth $1,680,000 after purchasing an additional 136 shares in the last quarter. Orion Porfolio Solutions LLC increased its position in shares of Integer by 1.4% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock valued at $1,200,000 after purchasing an additional 138 shares during the last quarter. Lido Advisors LLC raised its holdings in shares of Integer by 5.5% during the 4th quarter. Lido Advisors LLC now owns 2,887 shares of the medical equipment provider’s stock valued at $226,000 after buying an additional 151 shares in the last quarter. Finally, Glenmede Trust Co. NA lifted its position in Integer by 3.6% in the 1st quarter. Glenmede Trust Co. NA now owns 4,805 shares of the medical equipment provider’s stock worth $423,000 after buying an additional 166 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

Shares of NYSE:ITGR opened at $125.32 on Thursday. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. The company has a 50-day moving average price of $106.20 and a 200-day moving average price of $93.99. The company has a market cap of $4.26 billion, a price-to-earnings ratio of 34.24, a price-to-earnings-growth ratio of 2.96 and a beta of 0.61. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $126.14.

Integer (NYSE:ITGR) last posted its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The company had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. During the same period last year, the firm earned $1.55 earnings per share. Integer’s quarterly revenue was down 2.6% on a year-over-year basis. As a group, equities analysts anticipate that Integer Holdings Corporation will post 6.09 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ITGR. Truist Financial cut shares of Integer from a “buy” rating to a “hold” rating and increased their price target for the company from $110.00 to $127.00 in a research report on Monday, August 3rd. Citigroup boosted their price objective on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Piper Sandler cut shares of Integer from an “overweight” rating to a “hold” rating and set a $127.00 price objective for the company. in a research note on Monday, August 3rd. Wells Fargo & Company increased their target price on shares of Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a report on Tuesday, August 4th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a research report on Thursday, June 18th. One analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $109.86.

More Integer News

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Zacks raised its FY2026 EPS forecast to $6.13 from $6.05 and increased its estimates for Q2 2027 and Q1 2028 to $1.61 and $1.71, respectively. These upward revisions provide some support for the outlook.
• Neutral Sentiment: Zacks maintained a “Hold” rating on Integer. Its current full-year consensus EPS estimate is approximately $6.08, while the firm projects FY2027 EPS of $6.56 and FY2028 EPS of $6.85, indicating continued earnings growth but limited near-term conviction.
• Negative Sentiment: Zacks reduced estimates for Q3 2026 EPS to $1.63 from $1.68, Q4 2026 EPS to $1.70 from $1.77, Q1 2027 EPS to $1.46 from $1.50, Q3 2027 EPS to $1.72 from $1.87, Q4 2027 EPS to $1.77 from $1.90, FY2027 EPS to $6.56 from $6.87, and FY2028 EPS to $6.85 from $7.20. The broad reductions, particularly to full-year 2027 and 2028 forecasts, are likely the main reason the stock has weakened.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.